What iZafe does

iZafe Group AB is a Swedish MedTech company founded in 2008 and listed on Nasdaq First North Growth Market since 2018, headquartered in Stockholm with a team of approximately 10 employees. The company develops and markets digital medication management solutions centered on two core products: Dosell, a patented medication dispensing robot that automatically releases tablets in dose bags at prescribed times, issues reminders, and alerts caregivers when doses are missed; and Pilloxa, a SaaS platform with a connected smart pillbox acquired in November 2022 and aimed at pharmaceutical companies running clinical studies. A modular external Display add-on and a remote care platform were launched in Q1 2026, extending Dosell's reach to patients with cognitive impairment and enabling remote monitoring by healthcare providers.

The business model is pure recurring license revenue with no hardware sales; Annual Recurring Revenue (ARR) reached approximately 10 MSEK at the beginning of 2026, up 488% from approximately 1.7 MSEK a year earlier, and management is guiding to roughly 22.5 MSEK by year-end 2026. Q4 2025 net sales of 2,435 TSEK consisted entirely of recurring license revenue. Customers are concentrated in the public sector — Swedish municipalities and regions via the Adda national framework, regional procurements such as Region Jönköping (framework value up to SEK 82.5 million), and partner-served municipal deals in Norway, Iceland, and the Netherlands — alongside pharmaceutical companies using Pilloxa for clinical trials. Go-to-market is predominantly channel-driven through distribution partners (Adda, Atea Sverige AB, Vakt og Alarm AS, Skand ehf) and inclusion on national programs such as the Dutch Digizo.nu, supported by participation in healthcare exhibitions such as Vitalis and WHX Dubai. The company holds European patent EP4228584 for sensor-data-driven medication adjustment and has obtained ISO/IEC 27001 certification across the Group, both of which strengthen its position in public-sector tenders and cross-border expansion.

Name

iZafe

Legal name

iZafe Group AB

Website

https://izafe.se

Company type

Public

Founded year

2008

Headcount range

1–10 employees

Short description

iZafe Group AB is a Swedish MedTech company that develops the Dosell medication dispensing robot and Pilloxa SaaS platform, serving municipalities, healthcare providers, and pharmaceutical companies across the Nordics and selected European markets via a recurring license model.

Ownership category

akta.pro rank

Product category

Digital Medication Management

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)

akta.pro secondary industries

Remote Adherence Monitoring & Smart Dispenser Services (HSABALAI), Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH), Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)

Keywords

• Digital medication management
• Medication dispensing systems
• Medication adherence technology
• Clinical trial software
• E-health solutions

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Recurring License Revenues: iZafe Group generates revenue entirely from recurring license revenues with no hardware sales, marking a full transition from a hardware-dominated revenue model to a subscription-based business model. The company's annual recurring revenue (ARR) reached approximately 10 MSEK at the beginning of 2026, representing 488% year-over-year growth, with forecasts projecting ARR to reach 22.5 MSEK by year-end 2026.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels4 records

Core offering

iZafe Group AB develops and markets digital medication management solutions, led by Dosell — a patented medication dispensing robot that automatically dispenses tablets in dose bags at prescribed times, reminds patients when medication is due, and alerts caregivers when doses are missed. Through its wholly-owned subsidiary Pilloxa AB, the company also offers a SaaS platform with a connected smart pillbox for clinical trial patient engagement and real-time insights.

Product overview

iZafe Group offers a portfolio of digital medication management solutions built around two core products: Dosell, a patented medication dispensing robot that automates tablet dispensing and alerts caregivers to missed doses, and Pilloxa, a SaaS platform with smart pillbox technology for clinical studies. The company operates a subscription-based (SaaS) business model. The product portfolio also includes a modular external Display add-on and a remote care system, both launched in 2026 to expand Dosell's functionality for patients with cognitive impairment and enable remote monitoring by healthcare providers. All solutions are designed to reduce medication errors, increase adherence, and support safer medication management at home.

Differentiator

Problem solved

Functional benefit

Products and services

• Dosell Medication Dispensing Robot Patented medication dispensing robot for safer medication in the home and in elderly care residences. Automatically dispenses tablets in dose bags at prescribed times, reminds patients when medication is due, and alerts care staff when medication is missed. Reduces the risk of overdose, incorrect drug combinations, and missed medications.
• Pilloxa Clinical Study Platform SaaS solution and smart pillbox for clinical studies that provides real-time patient insights and improves data quality. Engages and involves patients throughout studies with an innovative digital platform supporting pharmaceutical companies and clinical trial operations.
• Dosell Modular External Display Modular external display solution designed to extend Dosell medication dispenser functionality to patients with cognitive impairment or those requiring additional visual guidance, broadening the target group and increasing value per installed unit.
• Dosell Remote Care System Remote care platform that complements the Dosell medication dispenser by enabling healthcare providers to monitor medication adherence and patient status remotely, supporting proactive care and remote healthcare delivery.

Quantifiable outcome

• Annual Recurring Revenue grew from approximately 1.7 MSEK at beginning of 2025 to approximately 10 MSEK at beginning of 2026, representing 488% year-over-year growth
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Region Jönköping County and its MunicipalitiescoreChannel Partner/ Reseller/ Distributor · 1 April 2026Dosell AB was awarded a sub-contract by Region Jönköping County and its municipalities for medication dispensing systems as part of a coordinated regional procurement. The framework agreement, effective April 1, 2026, runs for an initial two-year period with potential extension up to four years. The total estimated procurement value is approximately SEK 55 million with a maximum ceiling of SEK 82.5 million.
• Atea Sverige ABcoreChannel Partner/ Reseller/ Distributor · 1 April 2026Dosell AB selected as solution in procurement where Atea Sverige AB awarded agreement with Västerviks kommun and samverkande kommuner for delivery of medication dispensing robots. Agreement effective April 1, 2026, covering approximately 500 units representing approximately SEK 3.7 million in annual recurring revenue at full rollout.
• Adda Inköpscentral (ADDA)coreChannel Partner/ Reseller/ Distributor · 31 March 2026Dosell AB signed framework agreement with Adda Inköpscentral following the conclusion of the appeal period for Sweden's first national procurement of medication dispensing robots. The agreement enters into force on March 31, 2026, enabling municipalities and regions across Sweden to procure Dosell through Adda's purchasing system via call-offs under the framework.
• Digizo.numinorChannel Partner/ Reseller/ Distributor · 1 January 2026Approval for inclusion on the Dutch Digizo.nu national program, enabling broader market access in the Netherlands for healthcare technology solutions.
• Skand ehfcoreChannel Partner/ Reseller/ Distributor · 20 November 2025iZafe Group signed distribution agreement with Skand ehf to launch and sell the medication dispensing robot Dosell in Iceland. The initial order includes 300 units, with scheduled delivery in 2026, and is expected to generate SEK 2-3 million annually.
• Vakt og Alarm AScoreChannel Partner/ Reseller/ Distributor · 1 January 2025Distribution partnership with Vakt og Alarm AS for Norway, including joint win of public procurement covering six Norwegian municipalities. Implementation began February 1 with approximately 100 units.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Emerging players

• CareZone: Digital medication management platform that helps patients and caregivers manage medications, reminders, and refills. Comparable in the medication-adherence software/consumer-app layer of iZafe's Pilloxa offering.
• Catalia Health: Health companion robot that engages patients at home with medication reminders and adherence support. Overlaps with Dosell's reminder and caregiver-alert functionality, although the form factor and patient profile differ.
• Pillo Health: Voice-activated medication management and adherence device for the home, integrated with caregiver apps. Comparable to the modular Display and remote care system aspects of Dosell, although focused on a different interaction modality.

Direct peers

• Evondos: Finnish-headquartered provider of automated medication dispensing robots and remote monitoring services for home care, with an established Nordic municipal customer base. Evondos is the closest head-to-head competitor to Dosell in automated dose-bag dispensers for elderly home care.
• Hero Health: US-based connected medication management device that sorts and dispenses pills and tracks adherence, sold as a subscription to households. Direct functional comparable to Dosell on automated home dispensing and adherence monitoring.
• AdhereTech: Connected smart pill bottle and adherence analytics platform deployed primarily in clinical trials and specialty pharmacy programs. Comparable to the Pilloxa side of iZafe's portfolio, where connected packaging is paired with real-time adherence data.
• MedMinder: US-based smart pill dispenser provider serving elderly and chronic-disease patients at home, with remote monitoring and adherence alerts for caregivers. Comparable in product form factor and recurring service model to Dosell.

Broad incumbents

• BD (Becton Dickinson): Global medical technology company offering medication management solutions (including BD Pyxis and home infusion products). Overlaps with Dosell in medication safety, dispensing, and adherence, and is a potential strategic acquirer or competitor in European home care.
• Philips Medication Dispensing Service: Philips Lifeline offers a medication dispenser service for seniors, bundled with its broader remote patient monitoring and personal emergency response portfolio. While not a dose-bag robot, it competes for the same municipal and home-care procurement budgets for medication adherence.
• Omnicell: Large US-listed provider of medication management solutions for hospitals, pharmacies, and home care, including automated dispensing and adherence tools. Competes indirectly for healthcare-provider medication-management budgets and could expand downstream into home dispensing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries2 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iZafe